Founded in 1996, Eleolistat Capsule is a Class A over-the-counter drug, mainly used for the treatment of obesity or overweight patients, and is a pharmaceutical enterprise integrating drug research and development, production and sales
Eleolilistat capsules, Class A over-the-counter medicines, Eleolilistat capsules are capsules with white or off-white granules or powders. The manufacturer is Chongqing Huasen Pharmaceutical Co., Ltd. (formerly Chongqing Huasen Pharmaceutical Co., Ltd.).
Chongqing Huasen Pharmaceutical Co., Ltd. (stock abbreviation: Huasen Pharmaceutical, stock code: 002907) is located in Chongqing Rongchang District High-tech Zone and Chongqing Liangjiang New Area, the company is a national key high-tech enterprise integrating drug research and development, production and sales, a national contract-abiding and trustworthy enterprise, a leading enterprise in the national biological industry base, a national modern science and technology industrial base of traditional Chinese medicine, a center for advanced technology of traditional Chinese medicine, a postdoctoral research workstation and an academician expert workstation, an innovative enterprise in Chongqing, The first batch of technological innovation demonstration enterprises in Chongqing, Three Gorges Migrant Enterprises, and Chongqing Excellent Enterprise Technology Center. The company was rated as "Top 20 Innovative Pharmaceutical Enterprises in China in 2015" by the Ministry of Industry and Information Technology, and was rated as "National Intellectual Property Advantage Enterprise" by the State Intellectual Property Office. In 2016, the company was rated as "China's Top 50 Traditional Chinese Medicine R&D Strength" and "China's Top 50 Pharmaceutical R&D Brand Strength" by China Pharmaceutical R&D Center; It was rated as "the most valuable enterprise in China's pharmaceutical industry (unlisted)" by China Pharmaceutical Industry Information Center; In the same year, it was also rated as "Top 50 Enterprises in China's Pharmaceutical Industry", "Top 100 Enterprises in China's Pharmaceutical Manufacturing Industry" and "Law-abiding and Honest Enterprises" by the Pharmaceutical Chamber of Commerce of the All-China Federation of Industry and Commerce; It was awarded the "China Patent Award" by the State Intellectual Property Office and listed on the "China Pharmaceutical Brand List". In 2017, it won the "6th Chongqing Mayor Quality Management Award".
Huasen Pharmaceutical consists of Chongqing Huasen Biotechnology Co., Ltd., Chongqing Huasen Pharmaceutical Co., Ltd., and Chongqing Huasen Pharmacy Retail Chain Co., Ltd.
Huasen Pharmaceutical has built 11 leading production lines in China, including tablets, powders, granules, hard capsules, soft capsules, powder injections, lyophilized powder injections, small-volume injections, raw material synthesis and botanical drug extraction. In 2014, it successfully acquired 16 lyophilized powder injection products to further expand the company's product line. The company's products have always won the four 100% pass rates of finished product inspection, food and drug administration sampling, national evaluation sampling and market sampling. It has won the honorary titles of "Excellent Quality Management Team of China's Pharmaceutical Industry", "National Excellent Quality Management Team", and "Assured Medicine" of the Health News of the Ministry of Health, and enjoys a high reputation among consumers and medical workers.
